SCHEMBL18954626

SCHEMBL18954626

CC(C)(C)c1ccc2c(c1)C(=O)C(=O)N2Cc1ccccc1C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PARK7 Q99497 1/20 0.49
▸ CHRM5 P08912 4/20 0.47
▸ BCHE P06276 1/20 0.46
▸ CES1 P23141 1/20 0.46
▸ ACHE P22303 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.45
▸ ALDH2 P05091 2/20 0.45
▸ ALDH3A1 P30838 2/20 0.45
▸ TGM2 P21980 1/20 0.45
▸ TP53 P04637 1/20 0.45
▸ MAPT P10636 1/20 0.45
▸ CA12 O43570 2/20 0.44
▸ CA1 P00915 2/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CA9 Q16790 2/20 0.44
▸ HSP90AA1 P07900 1/20 0.43
▸ CASP1 P29466 1/20 0.41
▸ CASP3 P42574 1/20 0.41
▸ CASP4 P49662 1/20 0.41
▸ CASP7 P55210 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18954858 0.84 ACHE (0.63) PARK7CHRM5ACHEALDH1A1ALDH2
SCHEMBL18954793 0.81 ALDH3A1 (0.69) PARK7CHRM5BCHECES1ALDH1A1
SCHEMBL18955172 0.81 CTRC (0.54) PARK7CHRM5ACHEALDH1A1ALDH2
SCHEMBL18954751 0.81 ALDH1A1 (0.67) PARK7CHRM5CES1ACHEALDH1A1
SCHEMBL18954774 0.81 CHRM5 (0.66) PARK7CHRM5ALDH1A1ALDH2ALDH3A1
SCHEMBL18955277 0.81 PARK7 (0.63) PARK7CHRM5ALDH1A1ALDH3A1TP53
SCHEMBL18954848 0.81 PARK7 (0.49) PARK7CHRM5ACHEALDH1A1ALDH2
SCHEMBL18974327 0.81 CES1 (0.62) PARK7CHRM5BCHECES1ACHE
SCHEMBL18954540 0.79 PARK7 (0.49) PARK7CHRM5ACHEALDH1A1ALDH2
SCHEMBL18955176 0.78 CHRM5 (0.72) CHRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017099695-A1 N-[(AMINOSULFONYL)PHENYL]-2-(1,2-DIHYDRO-2-OXO-3H-INDOL-3-YLIDENE)-HYDRAZINECARBOTHIOAMIDE DERIVATIVES FOR TREATING CANCER AND IMMUNOLOGICAL DISORDERS ISTANBUL UNIVERSITESI REKTORLUGU (TR) 2017-06-15 — — WO disclosed
Send feedback